KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.
|KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD. Patent applications|
|Patent application number||Title||Published|
|20110044949||ONCOLYTIC VIRUS REPLICATING SELECTIVELY IN TUMOR CELLS - By using a virus having a gene sequence comprising a telomerase promoter and an E1 gene (preferably a sequence comprising E1A gene, IRES sequence and E1B gene) or by using an anticancer agent comprising the virus, the virus replicates in cancer cells to thereby produce an efficient anticancer effect.||02-24-2011|
|20090187288||REMOTE CONTROL SYSTEM - A remote control system capable of precise operations or treatments in which the visual recognition and operation portions are as close to each other as possible, including: a) an imaging device for taking an image of the object; b) a manipulation tool having at its tip an illuminator for casting a spot light onto the object; c) a driver for changing the position of the manipulation tool; d) an external display unit for displaying an image; e) an input unit for allowing an operator to specify a position corresponding to the display of the external display unit; f) a distance calculator for calculating the distance between the position specified through the input unit and the position of the spot light cast from the illuminator onto the object; and g) a controller for controlling, based on the aforementioned distance, the driver so as to bring the tip of the manipulation tool closer to the specified position.||07-23-2009|
|20090163432||Therapeutic Agent for Corneal Diseases - The present invention relates to a treatment agent for a disease or a disorder caused by a reduction in corneal endothelial cells, comprising as an active component at least one nucleic acid molecule inhibiting the expression of a connexin 43 gene.||06-25-2009|
Patent applications by KANSAI TECHNOLOGY LICENSING ORGANIZATION CO., LTD.